Enabling Early Disease Detection and Treatment Next Gen Patented - - PowerPoint PPT Presentation
Enabling Early Disease Detection and Treatment Next Gen Patented Detection Chemistry Replaces chemicals in Gold Standard $34B ELISA market Up to 30x sensitivity increase with standard instrumentation Accelerates drug discovery
Page 3
Immunomic Therapeutics (ITI): value proposition, market, competitive advantages and management
VALUE PROPOSITION: ITI’s LAMP-vax™ Technology is the “missing link” that enhances the effectiveness of DNA vaccines. It has the ability to make DNA vaccines work, which will reign in an era of simple, inexpensive and effective vaccinations for a wide spectrum of diseases. DNA and other nucleic acid vaccines have been in development since the 1990s, and with technologies such as ours that will make them a reality, this class of vaccines is poised to revolutionize the vaccine industry and public health as a whole. MARKETS: GLOBAL VACCINES, ALLERGY & ANIMAL HEALTH: The global human vaccine market is rapidly growing: Global market >$25 billion in 2011 with >30% AGR, Dominated by “Big 5” Pharma companies. The Allergy market is >$1.0B in 2010 for immunotherapeutics - Allergy Market is >$11B for symptom therapy. The Animal health vaccine sales were $4.0B in 2010, Fragmented market: companion & feedstock animals, Growth driven by entry into new markets like cancer & allergy. COMPETITIVE ADVANTAGES: DNA Vaccines as a class present great versatility, safety and simplicity. LAMP-vax DNA technology improves immunogenicity of DNA vacicnes through a low cost, scalable solution that eliminates the need for expensive and painful delivery systems such as electroporation and the danger and unknowns of molecular adjuvants such as cytokines. In particular, our technology’s advantages include: MHC-II Targeting Strategy Necessary for Clinical Relevancy, For Lysosomal Targeting, a Stablization Domain is Required, Proven Safety in the Clinic, Multiplexing Antigens, Plug & Play Vaccine Design for Rapid Product Line Development. MANAGEMENT: ITI’s Management Team includes experienced and respected biotechnology professionals providing strong scientific analysis supporting business management's efforts in innovative technology collaborations and creative business development. With collectively well over 100 years of industry relevant experience, ITI's Management Team is creating a world-class biotechnology company
Problem
–
Value Proposition
– DiskCorp’s industry leading repair technology delivers a solution for these destroyed HDDs – Substantially improves P&L by providing repair at 33% of the value of a new HDD
Solution
– Software based HDD Test & Repair; industry’s best yield 40% to 60%+ of failed HDD’s repaired
Executives
– DiskCorp’s management team’s 80-year history of providing Innovative data storage and aftermarket solutions –
–
information technology service
Market
– $23 Billion Market – Market Growth 14% per year – 50% not served due to security requirements
4
5
The Company
– Founded in 2010 focused on repair and recovery of HDD’s – Headquartered in San José, California – Revenue for fiscal year 2014 will be $1.6 Million
The Product
– DiskCorp technology opens the non-addressable portion of the market
Customers
– Symantec, Techway Services, Walmart – Round2 / Avnet, CTDI, Riverbed – Arrow Electronics
Competition
Repair Erasure
TeriSci Industries Blanco Tabernus Ji2
development/deployment of patient-integrated health solutions designed to monitor and prevent negative clinical outcomes, thereby saving health care dollars
across multiple platforms and health care systems
level of interventions needed.
multiple health care disciplines to help connect patient providers and improve clinical outcomes.
reporting requirements and ACO quality & care required measures.
room visits occur each year
billion/year
acute settings
health solutions to address and prevent negative clinical outcomes.
grew several companies in home medical equipment, home infusion, homecare respiratory and renal dialysis.
treatment equipment